Cellular regulation of SIRT1

Current Pharmaceutical Design

Volumn 15, Issue 1, 2009, Pages 39-44

  Milner, Jo ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

Author keywords

Basal; Cancer; Regulation; SIRT1; Stress; Therapy

Indexed keywords

HYPERMETHYLATED IN CANCER 1 PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; ONCOPROTEIN; PROTEIN P53; SIRTUIN 1; UNCLASSIFIED DRUG; SIRT1 PROTEIN, HUMAN; SIRTUIN;

APOPTOSIS; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL SURVIVAL; CELLULAR STRESS RESPONSE; COLON CANCER; DNA DAMAGE; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN STABILITY; REGULATORY MECHANISM; REVIEW; TUMOR SUPPRESSOR GENE; UPREGULATION; GENE EXPRESSION REGULATION; METABOLISM; NEOPLASM; PHYSIOLOGY;

GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASMS; SIRTUINS;

EID: 62149130110     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161209787185841     Document Type: Review

References (33)

1. Levine AJ, Feng Z, Mak TW, You H, Jin S. Coordination and communication between the p53 and IGF-1-AKT-TOR signal transduction pathways. Genes Dev 2006; 20: 267-75.
2. +/NADPH in Cellular Functions and Cell Death: Regulation and Biological Consequences. Antioxid Redox Signal 2008; 10: 179-206.
3. Porcu M, Chiarugi A. The emerging therapeutic potential of sirtuin- interacting drugs: From cell death to lifespan extension. Trends Pharmacol Sci 2005; 26: 94-103.
4. Blander G, Guarente L. The SIR2 family of protein deacetylases. Annu Rev Biochem 2004; 73: 417-35.
5. Anastasiou D, Krek W. SIRT1: Linking adaptive cellular responses to aging-associated changes in organismal physiology. Physiology 2006; 21: 404-10.
6. Jones PA, Baylin SB. The epigenomics of cancer. Cell 2007; 128: 683-92.
7. Kim E-J, Kho J-H, Kang M-R, Um S-J. Active regulator of SIRT1 cooperates with SIRT1 and facilitates suppression of p53 activity. Mol Cell 2007; 28: 277-90.
8. Kim J-E, Chen J, Lou Z. DBC1 is a negative regulator of SIRT1. Nature 2008; 451: 583-6.
9. Zhao W, Kruse J-P, Tang Y, Jung SY, Qin S, Gu W. Negative regulation of the deacetylase SIRT1 by DBC1. Nature 2008; 451: 587-90.
10. Yang Y, Fu W, Chen J, Olashaw N, Zhang X, Nicosia SV, et al. SIRT1 sumoylation regulates its deacetylase activity and cellular response to genotoxic stress. Nat Cell Biol 2007; 9: 1253-62.
11. Chen WY, Wang DH, Yen RC, Luo J, Gu W, Baylin SB. Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses. Cell 2005; 123: 437-48.
12. Langley E, Pearson M, Faretta M, Bauer UM, Frye RA, Minucci S, et al. Human SIR2 deacetylates p53 and antagonises PML/p53-induced cellular senescence. EMBO J 2002; 21: 2383-96.
13. Luo J, Nikolaev AY, Imai S, Chen D, Su F, Shiloh A, et al. Negative control of p53 by Sir2 promotes cell survival under stress. Cell 2001; 107: 137-48.
14. Vaziri H, Dessain SK, Ng Eaton E, Imai S, Frye RA, Pandita TK, et al. hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 2001; 107: 149-59.
15. Tang Y, Zhao W, Chen Y, Zhao Y, Gu W. Acetylation Is Indispensable for p53 Activation. Cell 2008; 133: 612-26.
16. Ford J, Ahmed S, Allison S, Jiang M, Milner J. JNK2-dependent regulation of SIRT1 protein stability. Cell Cycle 2008; 7: IN PRESS
17. Davis RJ. Signal transduction by the JNK group of MAP kinases. Cell 2000; 103: 239-252.
18. Chang L, Karin M. Mammalian MAP kinase signalling cascade. Nature 2001; 410: 37-40.
19. Sasaki T, Maier B, Bartke A, Scrable H. Progressive loss of SIRT1 with cell cycle withdrawal. Aging Cell 2006; 5: 413-22.
20. Abdelmohsen K, Pullman Jr. R, Lal A, Kim HH, Galban S, Yang X et al. Phosphorylation of HuR by ChK2 regulates SIRT1 expression. Mol Cell 2007; 25: 543-57.
21. Yamakuchi M, Ferlito M, Lowenstein CJ miR-34a repression of SIRT1 regulates apoptosis. PNAS 2008; 105: 13421-13426.
22. Maeda N, Toku S, Kenmochi N, Tanaka T. A novel nucleolar protein interacts with ribosomal protein S19. Biochem Biophys Res Commun 2006; 339: 41-46.
23. Murayama A., Ohmori K, Fujimura A, Minami H, Yasuzawa- Tanaka K, Kuroda T, et al. Epigenetic control of rDNA loci in response to intracellular energy status. Cell 2008; 133: 627-39.
24. Grummt I, Ladurner AG. A metabolic throttle regulates the epigenetic state of rDNA. Cell 2008; 133: 577-80.
25. Trauernicht AM, Kim SJ, Kim NH, Boyer TG. Modulation of estrogen receptor protein level and survival function by DBC-1. Mol Endocrinol 2007; 21: 1526-36.
26. Jiang M, Milner J. Bcl-2 constitutively suppresses p53-dependent apoptosis in colorectal cancer cells. Genes Dev 2003; 17: 832-837.
27. Ford J, Jiang M, Milner J. Cancer-specific functions of SIRT1 enable human epithelial cancer cell growth and survival. Cancer Res 2005; 65: 10457-63.
28. Firestein R, Blander G, Michan S, Oberdoerffer P, Ogino S, Campbell J, et al. The SIRT1 deacetylase suppresses intestinal tumorigenesis and colon cancer growth. PLoS One 2008; 3: E2020.
29. Neufeld KL. Nuclear APC. In: Näthke IS, McCartney BM, Eds. APC Proteins. Landes Bioscience. Pub date; 2008.
30. Caldwell CM, Kaplan KB. The Role of APC in Mitosis and in Chromosome Instability. In: Näthke IS, McCartney BM, Eds. APC Proteins. Landes Bioscience. Pub date; 2008.
31. Sansom O. Tissue-Specific Tumour Suppression by APC. In: Näthke IS, McCartney BM, Eds. APC Proteins. Landes Bioscience. Pub date; 2008.
32. Fodde, R. Kuipers J, Rosenberg C, Smits R, Kielman M, Gaspar C, et al. Mutations in the APC tumour suppressor gene cause chromosomal instability. Nat Cell Biol 2001; 3: 433-8.
33. Kielman MF, Rindapää M, Gaspar C, van Poppel N, Breukel C, van Leeuwen S, et al. Apc modulates embryonic stem-cell differentiation by controlling the dosage of β-catenin signaling. Nat Genetics 2002; 32: 594-605.